Effect of targeting inhibition of epidermal growth factor receptor expression by RNA interference on the proliferation of colon cancer cells
TAO Kai-xiong,WU Xiang-bai,WANG Guo-bin,陶凯雄,吴相柏,王国斌,陈道达,张宁,李新明
DOI: https://doi.org/10.3760/j.issn:1001-9030.2006.07.007
2006-01-01
Abstract:Objective To investigate whether RNA interference(RNAi)technique could effec- tively inhibit the expression of epidermal growth factor receptor(EGFR)and influence the proliferation of colon cancer LoVo cells.Methods pU6-EGFR-shRNA-1 and pU6-EGFR=shRNA-2 expressive vectors were established by Pgenesil-1 plasmid and EGFR short hairpin RNA(shRNA)synthesized in vitro. Twenty-four,48,72,96 and 144h after the liposome transient transfection,real time PCR and Western blot were used to detect the expression of EGFR,and flow cytometry to assay the cell cycle and apoptosis. The cell growth curve was obtained.Five groups were assigned:Group 1,Control LoVo cells;Group 2: Lipofectamine 2000;Group 3:Negative control plasmid vector HK;Group 4:pU6-EGFR-shRNA-1 plas- mid vector;Group 5:pU6-EGFR-shRNA-2 plasmid vector.Results In groups 4 and 5 after shRNA transfection,the expression of mRNA and protein was decreased,the count of G_0-G_1 cells increased,while S cells reduced,and the apoptosis increased,logarithmic growth phase delayed,more predominant in 48 h as compared with groups 1,2 and 3(P＜0.05),but with time passing,the interference effect was re- duced.Conclusion Both pU6-EGFR-shRNA-1 and pU6-EGFR-shRNA-2 could suppress the EGFR ex- pression of LoVo cells,block more cell arrest in G0 to G1 phase,induce apoptosis and inhibit proliferation. RNA interference targeting EGFR probably is the new strategy for genetic therapy for colon cancer.